Cargando…
A six-gene-based signature for breast cancer radiotherapy sensitivity estimation
Breast cancer (BRCA) represents the most common malignancy among women worldwide with high mortality. Radiotherapy is a prevalent therapeutic for BRCA that with heterogeneous effectiveness among patients. Here, we proposed to develop a gene expression-based signature for BRCA radiotherapy sensitivit...
Autores principales: | Chen, Xing, Zheng, Junjie, Zhuo, Min ling, Zhang, Ailong, You, Zhenhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711058/ https://www.ncbi.nlm.nih.gov/pubmed/33179733 http://dx.doi.org/10.1042/BSR20202376 |
Ejemplares similares
-
Identification of a six‐gene signature with prognostic value for patients with endometrial carcinoma
por: Wang, Yizi, et al.
Publicado: (2018) -
Identification of a 9‐gene prognostic signature for breast cancer
por: Tian, Zelin, et al.
Publicado: (2020) -
BRAF-activated WT1 contributes to cancer growth and regulates autophagy and apoptosis in papillary thyroid carcinoma
por: Chen, Xing, et al.
Publicado: (2022) -
Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
por: Han, Linzhi, et al.
Publicado: (2020) -
Uronic acid metabolic process–related gene expression–based signature predicts overall survival of glioma
por: Feng, Yuemei, et al.
Publicado: (2021)